Results 51 to 60 of about 27,170 (181)

Cimetidine Does Not Inhibit 5-Aminolevulinic Acid Synthase or Heme Oxygenase Activity: Implications for Treatment of Acute Intermittent Porphyria and Erythropoietic Protoporphyria

open access: yesBiomolecules, 2023
Acute intermittent porphyria (AIP) is characterized by acute neurovisceral attacks that are precipitated by the induction of hepatic 5-aminolevulinic acid synthase 1 (ALAS1).
Makiko Yasuda   +5 more
doaj   +1 more source

Erythropoietic protoporphyria in a child.

open access: yes, 1989
Erythropoietic protoporphyria (EPP), a recently described form of porphyria, often remains unrecognized. We report the case of a 7-year-old girl admitted for investigation of photosensitivity since the age of 18 months without any significant objective ...
Cornu, Guy   +3 more
core   +1 more source

Two Novel Mutations in FECH in a Patient With Erythropoietic Protoporphyria: A Case Report

open access: yesInternational Journal of Dermatology and Venerology, 2023
Introduction:. Erythropoietic protoporphyria (EPP) is a rare photodermatosis mainly caused by deficiency of the enzyme ferrochelatase (FECH). We herein report a case of EPP associated with 2 novel mutations in FECH. Case presentation:.
Qi Tan   +6 more
doaj   +1 more source

Erythropoietic protoporphyria without skin symptoms-you do not always see what they feel [PDF]

open access: yes, 2007
Erythropoietic protoporphyria (EPP) is an inherited disorder of the porphyrin metabolism that often remains undiagnosed in children. We report on a 4-year-old girl who had been suffering for 1 year from recurrent painful crises affecting her hands, feet,
Sigurdsson, Vigfus   +20 more
core   +1 more source

A low‐cost handheld device for monitoring cutaneous photosensitivity

open access: yesPhotochemistry and Photobiology, EarlyView.
The cutaneous photosensitivity detection (CPD) device is a handheld contact‐based measurement device using 405 nm excitation and red fluorescence detection for monitoring skin phototoxicity risk after photodynamic therapy (PDT) procedures involving systemic aminolaevulinic acid (ALA) induced protoporphyrin IX (PpIX) photosensitization.
Md Asaduzzaman Rasel   +4 more
wiley   +1 more source

When the diagnosis is written in the DNA: a case of erythropoietic protoporphyria in a patient with a chromosome 18 deletion

open access: yesDermatology Reports, 2023
We present a case of erythropoietic protoporphyria (EPP) in a 21-year-old man who sought medical attention in April 2022 due to diffuse edema and erythema of the hands, which he had been experiencing since childhood and occurring shortly after sun ...
Sara Rovaris   +8 more
doaj   +1 more source

Iron Homeostasis and Liver Diseases

open access: yesJournal of Cellular and Molecular Medicine, Volume 30, Issue 20, October 2026.
ABSTRACT Iron is an essential micronutrient whose ability to cycle between ferric (Fe3+) and ferrous (Fe2+) states makes it crucial for physiological processes, including oxygen transport, DNA synthesis, and oxidative phosphorylation. However, because both deficiency and excess can cause severe pathology, precise regulation is critical. The liver plays
Peng Yang   +6 more
wiley   +1 more source

Exonic deletions as a cause of erythropoietic protoporphyria

open access: yes, 2006
Erythropoietic protoporphyria (EPP) is an inherited disorder that results from partial deficiency of ferrochelatase (FECH), the terminal enzyme of haem biosynthesis.
McKenna, Kevin   +3 more
core   +1 more source

Bone marrow-derived cells promote liver regeneration in mice with erythropoietic protoporphyria [PDF]

open access: yes, 2009
Background: Bone marrow transplantation can reverse hepatic protoporphyrin accumulation and prevent the hepatobiliary complications characteristic of erythropoietic protoporphyria.
de Salamanca, RE   +13 more
core   +3 more sources

Exacerbation of erythropoietic protoporphyria by hyperthyroidism [PDF]

open access: yes, 2010
Erythropoietic protoporphyria (EPP) is a hereditary disorder caused by deficiency of ferrochelatase, the last enzyme in the heme biosynthetic pathway. The majority of EPP patients present with a clinical symptom of painful phototoxicity.
Xiaoye Schneider-Yin   +5 more
core   +1 more source

Home - About - Disclaimer - Privacy